Presidio Pharmaceuticals
San Francisco
About Presidio Pharmaceuticals
Presidio Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel therapeutics for viral infections, including HCV and HIV. Presidio has raised over $27 million in financing from Panorama Capital, Baker Brothers Investments, Bay City Capital, Ventures West, Nexus Medical Partners, and Sagamore Bioventures LLC.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $100.2M
- Funding stage: M&A
- Last round: Series D (Jun 2014)
- Website: presidiopharma.com
- Phone: 415-655-7560
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/presidio-pharmaceuticals-2647603 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.